Company news

OncoSil Medical Ltd news in 2022

OncoSil Medical Ltd's news releases, calls and decks from 2022, newest first.

View company

OncoSil achieves milestone of 10 patients treated in Spain

December 14, 2022

Distribution agreement signed for selected Chinese markets

December 13, 2022

2022 AGM CEO Presentation

October 25, 2022

OncoSil Receives $832k R&D Tax Incentive

October 23, 2022

OncoSil to Present at South-West Connect ASX Showcase

October 17, 2022

Appendix 4E Announcement

August 30, 2022

Investor Presentation

August 3, 2022

Monthly Activities/Appendix 4C Cash Flow Report

July 29, 2022

Patient treated in Spain proceeds to successful resection

July 18, 2022

Bupa UK Approves Reimbursement for OncoSil in the UK

July 3, 2022

FY 2023 Strategic Update

June 29, 2022

OncoSil PanCO Clinical Trial Presented At ESMO World WCGIC

June 28, 2022

Entitlement Offer Results and Shortfall Notification

June 9, 2022

OncoSil Entitlement Offer Booklet

May 10, 2022

Clarification Of Non-Renouncable Entitlement Offer Details

May 1, 2022

OncoSil Launches $10m Capital Raising

April 29, 2022

OncoSil Signs Commercial Agreement With Hospital In Spain

April 28, 2022

First Commerical Pancreas Treatment In Spain

April 12, 2022

Fully-Funded Trial Approved In Germany

March 27, 2022

Half Yearly Report Results

February 22, 2022

OncoSil approved for Innovation Funding (NUB) in Germany

February 2, 2022

Decks in 2022